7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-06-30 2016-03-31 2015-09-30 2014-03-31 2013-09-30 2013-06-30 2012-09-30 2012-06-30 2007-12-31 2007-03-31 2006-12-31 
      
    		                                              
      revenues
    		                                              
      product sales
    		2,657,000,000 2,504,000,000 2,227,000,000 2,528,000,000 2,482,000,000 2,379,000,000 2,129,000,000 2,382,000,000 2,213,000,000 2,146,000,000 1,922,000,000 2,175,000,000 2,026,000,000 1,947,000,000 1,898,000,000 2,175,000,000 2,088,000,000 2,076,000,000 2,003,000,000 2,190,000,000 2,111,000,000 1,637,000,000 1,986,000,000 2,198,000,000 2,180,000,000 2,122,000,000 1,989,000,000 2,098,000,000 2,108,000,000 2,100,000,000 1,965,000,000 2,133,000,000 2,186,000,000 2,200,000,000 2,076,000,000 2,388,700,000 2,336,100,000 2,748,200,000 1,851,100,000 1,506,421,000 1,063,513,000 856,892,000 748,742,000    
      other revenues
    		24,000,000 26,000,000 32,000,000 31,000,000 28,000,000 24,000,000 24,000,000 26,000,000 25,000,000 21,000,000 22,000,000 18,000,000 20,000,000 20,000,000 20,000,000 21,000,000 23,000,000 24,000,000 24,000,000 23,000,000 27,000,000 27,000,000 26,000,000 26,000,000 29,000,000 30,000,000 27,000,000 23,000,000 28,000,000 28,000,000 30,000,000 30,000,000 33,000,000 33,000,000 33,000,000 31,500,000 35,500,000 38,600,000 35,100,000        
      expenses
    		                                              
      cost of goods sold
    		735,000,000 748,000,000 683,000,000 711,000,000 682,000,000 708,000,000 628,000,000 695,000,000 612,000,000 640,000,000 572,000,000 645,000,000 578,000,000 570,000,000 543,000,000 619,000,000 574,000,000 604,000,000 564,000,000 637,000,000 578,000,000 482,000,000 505,000,000 622,000,000 571,000,000 580,000,000 524,000,000 592,000,000 573,000,000 584,000,000 560,000,000 637,000,000 650,000,000 635,000,000             
      cost of other revenues
    		15,000,000 16,000,000 18,000,000 16,000,000 14,000,000 11,000,000 12,000,000 10,000,000 11,000,000 9,000,000 10,000,000 7,000,000 6,000,000 7,000,000 8,000,000 7,000,000 8,000,000 8,000,000 10,000,000 8,000,000 12,000,000 13,000,000 14,000,000 13,000,000 13,000,000 14,000,000 13,000,000 10,000,000 9,000,000 10,000,000 13,000,000 10,000,000 9,000,000 11,000,000 12,000,000 10,500,000 9,700,000 13,600,000         
      selling, general and administrative
    		795,000,000 894,000,000 867,000,000 820,000,000 850,000,000 832,000,000 794,000,000 766,000,000 715,000,000 711,000,000 725,000,000 666,000,000 661,000,000 676,000,000 622,000,000 680,000,000 653,000,000 685,000,000 606,000,000 636,000,000 572,000,000 526,000,000 633,000,000 668,000,000 648,000,000 651,000,000 587,000,000 626,000,000 614,000,000 642,000,000 591,000,000 639,000,000 623,000,000 659,000,000 661,000,000 671,500,000 812,600,000 697,600,000 482,000,000 355,637,000 257,373,000 188,660,000 185,440,000    
      research and development
    		166,000,000 159,000,000 143,000,000 163,000,000 146,000,000 156,000,000 151,000,000 152,000,000 153,000,000 156,000,000 143,000,000 142,000,000 133,000,000 127,000,000 127,000,000 117,000,000 121,000,000 115,000,000 112,000,000 119,000,000 103,000,000 108,000,000 122,000,000 114,000,000 123,000,000 117,000,000 117,000,000 120,000,000 107,000,000 94,000,000 92,000,000 90,000,000 81,000,000 94,000,000 96,000,000 124,300,000 103,100,000 101,600,000 61,300,000 49,009,000 24,469,000 19,170,000 17,711,000    
      amortization of intangible assets
    		253,000,000 256,000,000 256,000,000 259,000,000 274,000,000 270,000,000 274,000,000 282,000,000 253,000,000 269,000,000 273,000,000 313,000,000 290,000,000 302,000,000 310,000,000 320,000,000 338,000,000 360,000,000 357,000,000 382,000,000 391,000,000 436,000,000 436,000,000 445,000,000 475,000,000 488,000,000 489,000,000 502,000,000 658,000,000 741,000,000 743,000,000 775,000,000 657,000,000 623,000,000 635,000,000      303,598,000 218,187,000 210,570,000    
      asset impairments
    		1,000,000   23,000,000  5,000,000 1,000,000 13,500,000 4,000,000 37,000,000 13,000,000         4,250,000 2,000,000 1,000,000 14,000,000 26,000,000 33,000,000 13,000,000 3,000,000 134,000,000 89,000,000 301,000,000 44,000,000 85,000,000 406,000,000 85,000,000 138,000,000            
      restructuring, integration and separation costs
    		17,000,000 31,000,000 1,000,000 6,250,000 1,000,000 12,000,000 12,000,000           9,000,000 12,000,000 9,000,000 2,000,000                          
      other income
    		80,000,000 -18,000,000 15,000,000 2,000,000 225,000,000 20,000,000   60,000,000 -83,000,000 23,000,000 29,000,000 4,000,000  2,000,000 44,000,000 -183,000,000 542,000,000 -30,000,000 308,000,000 16,000,000 107,000,000 23,000,000 1,399,000,000 10,000,000 8,000,000 -4,000,000 -17,000,000 -15,000,000  11,000,000 231,000,000 -325,000,000 -19,000,000 -240,000,000 -45,300,000 23,100,000 30,200,000 -43,300,000        
      operating income
    		619,000,000 444,000,000 276,000,000 558,000,000 318,000,000 389,000,000 281,000,000 362,000,000 14,000,000 412,000,000 175,000,000 -236,000,000 244,000,000 161,000,000 285,000,000 367,000,000 574,000,000 -270,000,000 -221,000,000 -5,000,000 460,000,000 -27,000,000 248,000,000 -1,076,000,000 329,000,000 257,000,000 287,000,000 25,000,000 117,000,000 -245,000,000 -2,281,000,000 -322,000,000 38,000,000 175,000,000 211,000,000 80,500,000 66,200,000 447,800,000 356,600,000 -891,498,000 141,513,000 29,464,000 86,810,000    
      yoy
    		94.65% 14.14% -1.78% 54.14% 2171.43% -5.58% 60.57% -253.39% -94.26% 155.90% -38.60% -164.31% -57.49% -159.63% -228.96% -7440.00% 24.78% 900.00% -189.11% -99.54% 39.82% -110.51% -13.59% -4404.00% 181.20% -204.90% -112.58% -107.76% 207.89% -240.00% -1181.04% -500.00% -42.60% -60.92% -40.83% -109.03% -53.22% 1419.82% 310.78%        
      qoq
    		39.41% 60.87% -50.54% 75.47% -18.25% 38.43% -22.38% 2485.71% -96.60% 135.43% -174.15% -196.72% 51.55% -43.51% -22.34% -36.06% -312.59% 22.17% 4320.00% -101.09% -1803.70% -110.89% -123.05% -427.05% 28.02% -10.45% 1048.00% -78.63% -147.76% -89.26% 608.39% -947.37% -78.29% -17.06% 162.11% 21.60% -85.22% 25.57% -140.00% -729.98% 380.29% -66.06%     
      operating margin %
    		                                              
      interest income
    		15,000,000 13,000,000 11,000,000 9,000,000 7,000,000 8,000,000 9,000,000 7,000,000 6,000,000 7,000,000 6,000,000 6,000,000 3,000,000 3,000,000 2,000,000 1,000,000 2,000,000 2,000,000 2,000,000 2,000,000 2,000,000 2,000,000 7,000,000 3,000,000 2,000,000 3,000,000 4,000,000 2,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 2,100,000 900,000 700,000 1,800,000 2,686,000 1,054,000 1,156,000 1,020,000    
      interest expense
    		-412,000,000 -465,000,000 -330,000,000 -337,000,000 -346,000,000 -350,000,000 -355,000,000 -363,000,000 -339,000,000 -319,000,000 -307,000,000 -307,000,000 -385,000,000 -410,000,000 -362,000,000 -343,000,000 -351,000,000 -364,000,000 -368,000,000 -379,000,000 -374,000,000 -385,000,000 -396,000,000 -391,000,000 -406,000,000 -409,000,000 -406,000,000 -414,000,000 -420,000,000 -435,000,000 -416,000,000 -448,000,000 -459,000,000 -459,000,000 -474,000,000 -472,500,000 -426,600,000 -420,200,000 -246,500,000 -249,306,000 -176,793,000 -116,042,000 -100,614,000    
      gain on extinguishment of debt
    		3,000,000 178,000,000    12,000,000 11,000,000     192,000,000 570,000,000 113,000,000                                 
      foreign exchange and other
    		-7,000,000 -30,000,000 -4,000,000 -21,000,000  -11,000,000 -15,000,000 -14,000,000 -7,000,000 -21,000,000 -10,000,000 -12,000,000 7,000,000 4,000,000 -7,000,000 -4,000,000 3,000,000 7,000,000 1,000,000 -4,000,000 -13,000,000  -13,000,000 -4,000,000 9,000,000 3,000,000  5,000,000  -9,000,000 27,000,000 20,000,000 19,000,000 39,000,000 29,000,000 13,100,000 -6,200,000 -34,000,000 -13,400,000 5,079,000 -10,082,000 -1,603,000 -4,238,000    
      income before income taxes
    		218,000,000 140,000,000 -47,000,000 209,000,000 -21,000,000 48,000,000 -69,000,000 -7,000,000 -326,000,000 79,000,000 -136,000,000 -357,000,000 439,000,000 -129,000,000                                 
      benefit from income taxes
    		-37,000,000 -12,000,000 -39,000,000 -111,000,000 -71,000,000 -49,000,000 -8,000,000 -45,250,000 -56,000,000      16,000,000   77,000,000    112,000,000 26,000,000 -47,000,000 18,000,000 9,000,000 74,000,000    -3,000,000      7,200,000          
      net income
    		181,000,000 128,000,000 -86,000,000 98,000,000 -92,000,000 -1,000,000 -77,000,000 -47,000,000 -382,000,000 27,000,000 -209,000,000 -410,000,000 403,000,000 -139,000,000 -66,000,000 72,000,000 191,000,000 -593,000,000 -607,000,000 -152,000,000 70,000,000 -325,000,000 -152,000,000 -1,517,000,000 -48,000,000 -170,000,000 -48,000,000 -342,000,000 -351,000,000 -872,000,000 -2,691,000,000 512,000,000 1,300,000,000 -37,000,000 629,000,000 -304,000,000 -372,900,000 51,700,000 -20,300,000 -971,975,000 10,866,000 7,645,000 -21,607,000    
      yoy
    		-296.74% -12900.00% 11.69% -308.51% -75.92% -103.70% -63.16% -88.54% -194.79% -119.42% 216.67% -669.44% 110.99% -76.56% -89.13% -147.37% 172.86% 82.46% 299.34% -89.98% -245.83% 91.18% 216.67% 343.57% -86.32% -80.50% -98.22% -166.80% -127.00% 2256.76% -527.82% -268.42% -448.62% -171.57% -3198.52% -68.72% -3531.81% 576.26% -6.05%        
      qoq
    		41.41% -248.84% -187.76% -206.52% 9100.00% -98.70% 63.83% -87.70% -1514.81% -112.92% -49.02% -201.74% -389.93% 110.61% -191.67% -62.30% -132.21% -2.31% 299.34% -317.14% -121.54% 113.82% -89.98% 3060.42% -71.76% 254.17% -85.96% -2.56% -59.75% -67.60% -625.59% -60.62% -3613.51% -105.88% -306.91% -18.48% -821.28% -354.68% -97.91% -9045.10% 42.13% -135.38%     
      net income margin %
    		                                              
      net (income) loss attributable to noncontrolling interest
    		-2,000,000         -1,000,000      -2,000,000 -3,000,000       -1,500,000 -1,000,000                      
      net income attributable to bausch health companies inc.
    		179,000,000 148,000,000 -58,000,000 93,000,000 -85,000,000 10,000,000 -64,000,000 -39,000,000 -378,000,000 26,000,000 -201,000,000 -410,000,000 399,000,000 -145,000,000 -69,000,000 69,000,000 188,000,000 -595,000,000 -610,000,000 -153,000,000 71,000,000 -326,000,000 -152,000,000 -1,516,000,000 -49,000,000 -171,000,000 -52,000,000 -344,000,000 -350,000,000 -873,000,000                 
      earnings per share attributable to bausch health companies inc.
    		                                              
      basic
    		0.48 0.4    0.03  -0.38 -1.03 0.07  0.128 1.1   -0.71 0.52   -0.288 0.2       -0.98 -1 -2.49 -7.68 1.46 3.71 -0.11 1.8 -0.88 -1.08 0.14  -2.92       
      diluted
    		0.48 0.4    0.03  -0.38 -1.03 0.07  0.128 1.1   -0.71 0.52   -0.288 0.2       -0.98 -1 -2.49 -7.68 1.45 3.69 -0.11 1.79 -0.88 -1.08 0.14  -2.92       
      weighted-average common shares
    		                                              
      basic
    		371.3 370.9    367.9   365.4 364.8   362.5    359.6    355.6   352.1   351.3 351.3 351.5 351.3 350.7 350.2 350.4 350.1 349.8 345 344.9 344.9  333,643 308,153 304,075 304,816    
      diluted
    		375.5 373.1    370.2   365.4 367.1   363.4    364    357.8   352.1   351.3 351.3 351.5 351.3 350.7 351.8 352.3 350.1 350.5 345 344.9 351  333,643 314,447 311,743 304,816    
      net income attributable to noncontrolling interest
    		 20,000,000 28,000,000 7,750,000 7,000,000  13,000,000      -4,000,000 -6,000,000 -3,000,000   -2,000,000 -3,000,000   -1,000,000    -1,000,000 -4,000,000   -1,000,000                 
      basic and diluted loss per share attributable to bausch health companies inc.
    		  -0.16 0.25 -0.23  -0.17    -0.55   -0.4 -0.19   -1.66 -1.71   -0.92 -0.43 -0.193 -0.14                      
      basic and diluted weighted-average common shares
    		  369.6 368 368.4  366.8 364.9   363.3 362  362.2 360.8 358.9  359.1 356.8 355  355.3 353.4  352.4 352.1                     
      goodwill impairments
    		       91,000,000 402,000,000   622,000,000 119,000,000 83,000,000     469,000,000         109,000,000   2,213,000,000  312,000,000              
      net income (income) attributable to noncontrolling interest
    		     11,000,000  8,000,000 4,000,000  8,000,000          1,000,000       -500,000 1,000,000                  
      restructuring, integration, separation and ipo costs
    		       22,000,000 14,000,000 16,000,000 10,000,000 5,000,000 10,000,000 35,000,000 13,000,000 21,000,000 8,000,000                              
      (benefit from) benefit from income taxes
    		         -52,000,000 -73,000,000 -53,000,000 -36,000,000 -10,000,000  9,000,000 -25,000,000  -16,000,000 33,250,000 -5,000,000       -18,500,000 -51,000,000 -138,000,000                 
      asset impairments, including loss on assets held for sale
    		            1,000,000 6,000,000 8,000,000 21,000,000 18,000,000 47,000,000 148,000,000                            
      loss on extinguishment of debt
    		                -12,000,000 -45,000,000 -5,000,000 -8,000,000  -27,000,000 -24,000,000 -2,000,000  -33,000,000 -7,000,000 -44,000,000  -48,000,000 -27,000,000 -57,000,000 -1,000,000  -64,000,000    -93,700,000 -8,161,000  -2,322,000     
      income before benefit from income taxes
    		              -82,000,000 21,000,000 216,000,000 -670,000,000 -591,000,000 -394,000,000 75,000,000 -437,000,000 -178,000,000 -1,470,000,000 -66,000,000 -179,000,000 -122,000,000 -426,000,000 -300,000,000 -734,000,000 -2,694,000,000      -365,700,000          
      acquisition-related contingent consideration
    		                   22,000,000 2,000,000 11,000,000 13,000,000 10,000,000 3,000,000 20,000,000 -21,000,000 14,000,000 -19,000,000 -6,000,000 2,000,000 8,000,000 -238,000,000 -49,000,000 -10,000,000 6,900,000 2,400,000 3,800,000 8,900,000 -34,995,000 3,669,000 5,630,000 7,729,000    
      restructuring and integration costs
    		                     7,000,000 4,000,000 3,000,000 4,000,000 4,000,000 20,000,000 6,000,000 3,000,000 7,000,000 6,000,000 10,000,000 6,000,000 18,000,000 18,000,000            
      basic and diluted loss per share attributable to bausch health companies inc.:
    		                         -0.49                     
      acquired in-process research and development costs
    		                          1,000,000    1,000,000   1,000,000 4,000,000            
      loss per share attributable to bausch health companies inc.:
    		                                              
      basic
    		                          -0.15                    
      diluted
    		                          -0.15                    
      earnings per share attributable to bausch health companies inc.:
    		                                              
      basic
    		0.48 0.4    0.03  -0.38 -1.03 0.07  0.128 1.1   -0.71 0.52   -0.288 0.2       -0.98 -1 -2.49 -7.68 1.46 3.71 -0.11 1.8 -0.88 -1.08 0.14  -2.92       
      diluted
    		0.48 0.4    0.03  -0.38 -1.03 0.07  0.128 1.1   -0.71 0.52   -0.288 0.2       -0.98 -1 -2.49 -7.68 1.45 3.69 -0.11 1.79 -0.88 -1.08 0.14  -2.92       
      less: net income attributable to noncontrolling interest
    		                              2,000,000 250,000 -1,000,000 1,000,000 1,000,000 -1,700,000 800,000 2,200,000 2,300,000 1,268,000       
      net income attributable to valeant pharmaceuticals international, inc.
    		                              -2,693,000,000 513,000,000 1,301,000,000 -38,000,000 628,000,000 -302,300,000 -373,700,000 49,500,000 -22,600,000 -973,243,000       
      earnings per share attributable to valeant pharmaceuticals international, inc.:
    		                                              
      basic
    		0.48 0.4    0.03  -0.38 -1.03 0.07  0.128 1.1   -0.71 0.52   -0.288 0.2       -0.98 -1 -2.49 -7.68 1.46 3.71 -0.11 1.8 -0.88 -1.08 0.14  -2.92       
      diluted
    		0.48 0.4    0.03  -0.38 -1.03 0.07  0.128 1.1   -0.71 0.52   -0.288 0.2       -0.98 -1 -2.49 -7.68 1.45 3.69 -0.11 1.79 -0.88 -1.08 0.14  -2.92       
      income before recovery of income taxes
    		                               -234,250,000 -400,000,000 -242,000,000      -1,141,200,000  -89,347,000     
      recovery of income taxes
    		                               -707,250,000 -1,700,000,000 -205,000,000      -169,225,000  -96,992,000     
      cost of goods sold (excluding amortization and impairments of
    		                                              
      intangible assets)
    		                                  584,000,000            
      income before (recovery of) benefit from income taxes
    		                                  -295,000,000 -376,800,000  -5,700,000         
      (recovery of) benefit from income taxes
    		                                  -924,000,000 -72,800,000  -57,400,000         
      operating expenses
    		                                              
      cost of goods sold (exclusive of amortization and impairments of
    		                                              
      finite-lived intangible assets shown separately below)
    		                                   647,300,000 620,200,000 634,600,000 504,100,000 560,855,000       
      amortization and impairments of finite-lived intangible assets
    		                                   887,600,000 694,500,000 679,200,000 355,200,000 910,248,000       
      restructuring, integration and other costs
    		                                   19,500,000 38,000,000 75,600,000 133,600,000 295,890,000 53,665,000 42,872,000 30,004,000    
      in-process research and development impairments and other charges
    		                                   17,400,000  95,800,000 12,000,000 123,981,000 4,830,000      
      acquisition-related costs
    		                                    1,800,000 7,000,000 1,500,000 8,650,000 7,879,000 4,605,000 13,867,000    
      weighted-average common shares outstanding
    		                                              
      basic
    		371.3 370.9    367.9   365.4 364.8   362.5    359.6    355.6   352.1   351.3 351.3 351.5 351.3 350.7 350.2 350.4 350.1 349.8 345 344.9 344.9  333,643 308,153 304,075 304,816    
      diluted
    		375.5 373.1    370.2   365.4 367.1   363.4    364    357.8   352.1   351.3 351.3 351.5 351.3 350.7 351.8 352.3 350.1 350.5 345 344.9 351  333,643 314,447 311,743 304,816    
      gain on investments
    		                                        3,963,000  -35,000    
      cost of alliance and service revenues
    		                                      14,300,000 14,353,000 14,459,000 10,582,000 12,483,000    
      income before benefit from (recovery of) income taxes
    		                                      4,800,000    -17,057,000    
      benefit from (recovery of) income taxes
    		                                      25,100,000    4,550,000    
      loss per share attributable to valeant pharmaceuticals international, inc.:
    		                                              
      basic and diluted
    		                                      -0.07        
      weighted-average common shares
    		                                              
      basic and diluted
    		                                      334.9        
      alliance and royalty
    		                                       16,471,000 13,922,000 12,248,000 56,869,000    
      service and other
    		                                       18,839,000 18,327,000 15,000,000 14,479,000    
      legal settlements and related fees
    		                                       149,601,000 1,124,000      
      cost of goods sold (exclusive of amortization of
    		                                              
      intangible assets shown separately below)
    		                                        283,183,000 219,670,000 197,284,000    
      income before (recovery of ) benefit from income taxes
    		                                        -40,345,000      
      (recovery of ) benefit from income taxes
    		                                        -51,211,000      
      basic earnings per share
    		                                        0.04 0.03 -0.07    
      diluted earnings per share
    		                                        0.03 0.02 -0.07    
      acquired in-process research and development
    		                                         145,300,000 4,568,000    
      legal settlements
    		                                          53,624,000    
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.